Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Nanogen Expands Real-Time Portfolio

April 25th, 2006

Nanogen Expands Real-Time Portfolio

Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products announced today it has expanded its molecular reagent product portfolio to include real-time probes and primers designed to detect the presence of Epstein-Barr virus (EBV). EBV is the causative agent of infectious mononucleosis and also underlies several other lymphoproliferative disorders such as Burkitt's lymphoma.

Source:
Nanogen

Bookmark:

Related News Press

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages March 10th, 2014

Production of New Type of Electrochemical Drug Sensors for Cardiovascular Diseases March 10th, 2014

Iran Applying Nanotechnology in Growing Number of Industries March 10th, 2014

Aptasensors Help Detection of Cancer Protein Marker March 9th, 2014

Announcements

Iran Applying Nanotechnology in Growing Number of Industries March 10th, 2014

Analysis of Electromagnetic Performance, Coupling of Couple Nanoholes March 10th, 2014

A bright future for optoelectronics: A diode made from a 2D material facilitates novel solar cells March 10th, 2014

Scientists build thinnest-possible LEDs to be stronger, more energy efficient March 10th, 2014

	The latest news from around the world, FREE

Premium Products
	Only the news you want to read!  Learn More
	University Technology Transfer & Patents  Learn More
	Full-service, expert consulting  Learn More

Nanotechnology Now Featured Books